daniel petrylak, md, on treating bladder cancer patients progressing on checkpoint inhibitors
Published 7 years ago • 26 plays • Length 1:11
Download video MP4
Download video MP3
Similar videos
-
3:03
daniel petrylak, md, discusses the role of checkpoint inhibition therapy in urothelial carcinoma
-
0:39
daniel petrylak, md, offers recommendations for bladder cancer patients
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
1:01
david j. mcconkey, phd, on treating bladder cancer with checkpoint inhibitors
-
1:53
dr daniel petrylak explains pd-1, pd-l1 expression in bladder cancer treatment
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
2:51
fda approves new bladder cancer drug | dr. daniel petrylak
-
7:17
who is the copernicus of cancer? & why?
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
17:44
immune checkpoint inhibitors in lymphoma
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
0:51
daniel p. petrylak, md, regarding pd-l1 biomarkers in the treatment of bladder cancer
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
1:14
how can we continue the success of checkpoint inhibitors for bladder cancer treatment?
-
0:53
dr. siefker-radtke on fda approval of durvalumab in bladder cancer
-
0:58
daniel p. petrylak, md, on immunotherapy & chemotherapy combinations in metastatic bladder cancer
-
0:31
daniel petrylak, md, expresses the efficacy of infigratinib in fgfr3-altered muc patients
-
0:47
daniel p. petrylak, md, on molecular characterization & bladder subtyping in bladder cancer
-
4:43
impact of immune checkpoint inhibitors on care of patients with advanced bladder cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
0:56
meet oncologist daniel petrylak, md
Clip.africa.com - Privacy-policy